Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Non-Current Deffered Revenue (2016 - 2020)

National Healthcare (NHC) has disclosed Non-Current Deffered Revenue for 11 consecutive years, with $5.0 million as the latest value for Q1 2020.

  • For the quarter ending Q1 2020, Non-Current Deffered Revenue fell 1.3% year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Mar 2020, down 1.3%, and an annual FY2019 reading of $3.1 million, up 2.69% over the prior year.
  • Non-Current Deffered Revenue was $5.0 million for Q1 2020 at National Healthcare, up from $3.1 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $5.6 million in Q1 2017 and bottomed at $3.1 million in Q4 2018.
  • Average Non-Current Deffered Revenue over 5 years is $4.3 million, with a median of $4.4 million recorded in 2019.
  • The sharpest move saw Non-Current Deffered Revenue grew 3.85% in 2017, then fell 6.04% in 2018.
  • Year by year, Non-Current Deffered Revenue stood at $3.4 million in 2016, then dropped by 4.05% to $3.2 million in 2017, then fell by 5.33% to $3.1 million in 2018, then rose by 2.69% to $3.1 million in 2019, then surged by 59.63% to $5.0 million in 2020.
  • Business Quant data shows Non-Current Deffered Revenue for NHC at $5.0 million in Q1 2020, $3.1 million in Q4 2019, and $3.8 million in Q3 2019.